You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 15 No. 6, December 1966 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

A Neurochemical Study of a Case of Sudanophilic Leukodystrophy

BRUNO GERSTL, MD; LUCIEN J. RUBINSTEIN, MD; LAWRENCE F. ENG, PhD; MILITIZA TAVASTSTJERNA, DSc

Arch Neurol. 1966;15(6):603-614.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE NOSOLOGICAL definition of diffuse sudanophilic cerebral sclerosis has had a long and confused history. In 1956 Poser and van Bogaert1 reached, on morphological grounds, the conclusion that the eponymic entity commonly termed "Schilder's disease" consisted of three kinds of conditions: (1) Schilder's cerebral sclerosis, a disease closely resembling, if not identical with, multiple sclerosis; (2) The leukodystrophies, a group of heredodegenerative diseases, related to metabolic disorders such as the lipidoses and glycogenoses2,3; and (3) Examples of subacute encephalitis, including Dawson's inclusion body encephalitis, van Bogaert's subacute sclerosing leukoencephalitis, and Pette-Doring's nodular pancephalitis.

The exclusion of Schilder's disease and its transitional forms to multiple sclerosis from the complex group of the leukodystrophies was endorsed by Norman.4 In the latter group, however, there remained a heterogeneous collection of sporadic and familial cases in which the demyelinative process, though having the morphological features of a leukodystrophy, was characterized . . . [Full Text PDF of this Article]


Author Affiliations

PALO ALTO, CALIF

From the Department of Pathology, Stanford University School of Medicine, and the Laboratory Service, Veterans Administration Hospital, Palo Alto, Calif.


Footnotes

Submitted for publication June 15, 1966; accepted July 25.

Read in part before the Western Federation of Neurological Sciences Meeting, San Francisco, March 4, 1966.

Reprint requests to Department of Pathology, Stanford University School of Medicine, Palo Alto, Calif 94304 (Dr. Gerstl).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1966 American Medical Association. All Rights Reserved.